Cervical cancer, 8 HPV types in focus

Scientists have identified the eight human papillomavirus (HPV) types responsible for more than 90% of cervical cancer cases worldwide and say they should be the targets for the next generation of vaccines.

“IT applications serve as the backbone of our operations” : Dr Sumit Dutta, General Manager – Quest Diagnostics, India

As the Vice President and General Manager of Quest Diagnostics, Dr Sumit Dutta is responsible for creating an environment of quality, integrity and success for patients, customers and employees. Today, Quest Diagnostics is one of the largest pathology laboratories in the world.

States asked to stop HPV vaccine project

The Centre has advised the state governments to suspend the human papilloma virus vaccine programme in the wake of reports of violation of ethical guidelines and exploitation during the clinical trials of the vaccine for preventing cervical cancer among women.

Biocon and HCG Group of Hospitals Ltd. Join Hands to Fight Against Cervical Cancer

Biocon and HCG group of hospitals have announced their partnership to conduct a study to uate the potential benefits of BIOMAb EGFR

GCS to pump in INR 722 cr to upgrade Cancer Hospital

The utive board and general board of GCS, which runs the Cancer hospital, recently approved an ambitious plan to to convert the hospital into a super speciality cancer care and research institute that will provide treatment at par with international standards.

FUJIFILM SHOWCASES DIGITAL MAMMOGRAPHY, 8 March 2008, Le Meridien, Chennai : Kenichi-Tanaka, Managing Director, FUJIFILM India

[This article was published in the April 2008 issue of the eHEALTH Magazine (https://www.ehealthonline.org)]

To celebrate the spirit of International Women�s Day, FUJIFILM Corporation organised a seminar to spread awareness about breast cancer in India.